ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jul 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
September 2026
Nuclear Technology
August 2026
Fusion Science and Technology
Latest News
NRC accepts Ginna SLR application as Constellation seeks 20-year extension
The Nuclear Regulatory Commission has accepted Constellation’s subsequent license renewal application to extend operations at the Ginna nuclear power plant by another 20 years.
If approved, the Ontario, N.Y., facility’s operating license would be extended through September 18, 2049. The plant was first issued a 40-year license in 1969, followed by a 20-year renewal in 2004 that extended the license into 2029.
R. T. Santoro, R. A. Lillie, R. G. Alsmiller, Jr, J. M. Barnes
Nuclear Technology | Volume 47 | Number 3 | March 1980 | Pages 412-420
Technical Paper | Reactor | doi.org/10.13182/NT80-A32395
Articles are hosted by Taylor and Francis Online.
Two-dimensional discrete-ordinates calculations have been performed to determine the location and thickness of concrete shielding around the Tokamak Fusion Test Reactor neutral beam injectors. Two sets of calculations were performed, one to determine the dose equivalent rate on the roof and wall of the test cell building when no injectors are present, and one to determine the contribution to the dose equivalent rate at these locations from radiation streaming through the injection duct. Shielding the side and rear of the neutral beam injector with 0.305 and 0.61 m of concrete, respectively, and lining the inside of the test cell wall with an additional layer of concrete having a thickness of 0.305 m and a height above the axis of deuteron injection of 3.10 m is sufficient to maintain the biological dose equivalent rate outside the test cell to ∼1 mrem/D-T pulse.